Francesca Manag˛
Cited by
Cited by
Chronic and acute intranasal oxytocin produce divergent social effects in mice
H Huang, C Michetti, M Busnelli, F Manago, S Sannino, D Scheggia, ...
Neuropsychopharmacology 39 (5), 1102-1114, 2014
Oxytocin signaling in the central amygdala modulates emotion discrimination in mice
V Ferretti, F Maltese, G Contarini, M Nigro, A Bonavia, H Huang, ...
Current Biology 29 (12), 1938-1953. e6, 2019
Autism-related behavioral abnormalities in synapsin knockout mice
B Greco, F Manag˛, V Tucci, HT Kao, F Valtorta, F Benfenati
Behavioural brain research 251, 65-74, 2013
Somatostatin interneurons in the prefrontal cortex control affective state discrimination in mice
D Scheggia, F Manag˛, F Maltese, S Bruni, M Nigro, D Dautan, P Latuske, ...
Nature neuroscience 23 (1), 47-60, 2020
Automatic visual tracking and social behaviour analysis with multiple mice
L Giancardo, D Sona, H Huang, S Sannino, F Manag˛, D Scheggia, ...
PloS one 8 (9), e74557, 2013
Rapid generation of functional dopaminergic neurons from human induced pluripotent stem cells through a single-step procedure using cell lineage transcription factors
I Theka, M Caiazzo, E Dvoretskova, D Leo, F Ungaro, S Curreli, F Manag˛, ...
Stem cells translational medicine 2 (6), 473-479, 2013
Genetic disruption of Arc/Arg3. 1 in mice causes alterations in dopamine and neurobehavioral phenotypes related to schizophrenia
F Manago, M Mereu, S Mastwal, R Mastrogiacomo, D Scheggia, ...
Cell reports 16 (8), 2116-2128, 2016
Metabotropic glutamate receptors 5 blockade reverses spatial memory deficits in a mouse model of Parkinson's disease
E De Leonibus, F Manago, F Giordani, F Petrosino, S Lopez, A Oliverio, ...
Neuropsychopharmacology 34 (3), 729-738, 2009
Role of dopamine receptors subtypes, D1-like and D2-like, within the nucleus accumbens subregions, core and shell, on memory consolidation in the one-trial inhibitory avoidanceá…
F Manago, C Castellano, A Oliverio, A Mele, E De Leonibus
Learning & Memory 16 (1), 46-52, 2009
NEGR1 and FGFR2 cooperatively regulate cortical development and core behaviours related to autism disorders in mice
J Szczurkowska, F Pischedda, B Pinto, F Manago, CA Haas, M Summa, ...
Brain 141 (9), 2772-2794, 2018
COMT genetic reduction produces sexually divergent effects on cortical anatomy and working memory in mice and humans
S Sannino, A Gozzi, A Cerasa, F Piras, D Scheggia, F Manag˛, ...
Cerebral cortex 25 (9), 2529-2541, 2015
Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder
M Mereu, G Contarini, EF Buonaguro, G Latte, F Manag˛, F Iasevoli, ...
Neuropharmacology 121, 179-194, 2017
SINEUP non-coding RNA targeting GDNF rescues motor deficits and neurodegeneration in a mouse model of Parkinson’s disease
S Espinoza, M Scarpato, D Damiani, F Manag˛, M Mereu, A Contestabile, ...
Molecular Therapy 28 (2), 642-652, 2020
Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment
D Scheggia, R Mastrogiacomo, M Mereu, S Sannino, RE Straub, ...
Nature communications 9 (1), 2265, 2018
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans
GM Leggio, SA Torrisi, R Mastrogiacomo, D Mauro, M Chisari, C Devroye, ...
Molecular psychiatry 26 (4), 1272-1285, 2021
Role of catechol-O-methyltransferase (COMT)-dependent processes in Parkinson’s disease and L-DOPA treatment
S Espinoza, F Manag˛, D Leo, T D Sotnikova, R R Gainetdinov
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNSá…, 2012
Adolescence is the starting point of sex-dichotomous COMT genetic effects
S Sannino, MC Padula, F Manag˛, M Schaer, M Schneider, M Armando, ...
Translational psychiatry 7 (5), e1141-e1141, 2017
Dopamine, cognitive impairments and second-generation antipsychotics: from mechanistic advances to more personalized treatments
SA Torrisi, S Laudani, G Contarini, A De Luca, F Geraci, F Manag˛, ...
Pharmaceuticals 13 (11), 365, 2020
Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex
D Scheggia, E Zamberletti, N Realini, M Mereu, G Contarini, V Ferretti, ...
Molecular psychiatry 23 (4), 1040-1050, 2018
The role of GRK6 in animal models of Parkinson's Disease and L-DOPA treatment
F Manag˛, S Espinoza, A Salahpour, TD Sotnikova, MG Caron, ...
Scientific Reports 2 (1), 301, 2012
The system can't perform the operation now. Try again later.
Articles 1–20